Pharmacyclics, Inc. - Common Stock

(RTTNews.com) - The biotechnology sector, though a risky investment arena, offers a tremendous potential for huge gains. Binary events like clinical trial results and FDA decisions are typical in biotechnology companies, and can cause significant ...

(RTTNews.com) - Pharmacyclics Inc. (PCYC) gapped up at the open Friday, but moved in a narrow range during the first half hour of trade.

Pharmacyclics (NASDAQ:PCYC) is one of today's notable stocks in decline, down 1.8% to $18.43. The Dow Jones Industrial Average is now trading 0.4% lower to 12603 and the S&P is trading 0.2% lower to 1310.

Below are the top 10 rebounding Small Cap stocks, ranked based on % change from 52-week lows. Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) is the 1st best rebounding stock in this segment of the market.

Insiders have made significant new stock buys in 2012. These investments are being made in a wide variety of industries from publishing to truck makers to biotechnology.